Epalrestat is used to manage diabetic neuropathy, a condition characterized by nerve damage due to diabetes. It works by inhibiting the enzyme aldose reductase, which prevents the accumulation of sorbitol in nerve cells, thereby alleviating nerve pain. Epalrestat's clinical relevance lies in its ability to improve nerve function and reduce diabetic neuropathy symptoms. In summary, Epalrestat is a vital treatment for managing diabetic nerve pain.
Epalrestat inhibits aldose reductase, reducing sorbitol accumulation and preventing nerve damage in diabetic patients.





